ライフサイエンスコーパス: infiltrating

1 SGs (ISG(low)), low viral loads and abundant infiltrating activated CD8(+) T cells and macrophages.

2 Infiltrating adipose tissue (inFAT) is a newly recognize

3 dysplastic glands and indian file-like cells infiltrating adipose tissue.

4 bpopulations with different degrees of tumor-infiltrating and anti-inflammatory capabilities.

5 n are important methods in the prediction of infiltrating and non-infiltrating lymph nodes, and the d

6 ained with this interface were examined with infiltrating and noninfiltrating tumors, and were compar

7 ls, but rather a heterogeneous collection of infiltrating and resident host cells, secreted factors a

8 s has begun to define the phenotypes of both infiltrating and resident immune cells, as well as paren

9 text of acute inflammation and discover both infiltrating and tissue-resident immune cells to be visi

10 atients and shows that circulating and tumor-infiltrating ARG1-expressing cells were mainly immature

11 nalysis reveals versatile functions of tumor-infiltrating B cells and their potential clinical implic

12 Tumor-infiltrating B cells are heterogeneous, and their roles

13 nses in human cancer and suggest that tumour-infiltrating B cells could be harnessed for the developm

14 ral triggers underlie the development of CNS-infiltrating B cells is not fully understood.

15 In fact, a large proportion of islet-infiltrating B lymphocytes in the NOD mouse model of T1D

16 y eliminated long-term repopulating LSCs and infiltrating blast cells, conferring a survival advantag

17 ed tumor cell areas, tumor stroma, and tumor-infiltrating blood vessels.

18 enocarcinoma (PDA) populated by CD8+ T cells infiltrating both murine and human tumors.

19 sident CD11b/CD45(int)Ly6C(-) microglia, and infiltrating CD11b(+)/CD45(high) monocytes/macrophages c

20 r rejection, associated with increased tumor-infiltrating CD4 and CD8 T cells.

21 PD-1 and CTLA-4 were upregulated on tumor-infiltrating CD4(+) and CD8(+) T cells in irradiated and

22 Surprisingly, sciatic nerve-infiltrating CD4(+) cells had an expansion of IFN-gamma(

23 Nerve and islet-infiltrating CD4(+) T cells also differed by expression

24 depletion promoted GzmB expression by tumor-infiltrating CD4(+), and this was prevented by interleuk

25 ze was negatively associated with numbers of infiltrating CD4+ T cells, CD4+CD127+ T cells, and CD8+C

26 Carbon monoxide did not affect the number of infiltrating CD45(+) cells in the prostates of E. coli-

27 is often correlates with the number of tumor-infiltrating CD8 T cells, but many of these cells recogn

28 n intratumoral IL-2 and 2.1-fold increase in infiltrating CD8 T cells, resulting in significantly slo

29 significantly increased the number of tumor-infiltrating CD8(+) T and natural killer cells, slowed t

30 4-deficient tumors increased cytotoxic tumor-infiltrating CD8(+) T cells and elevated secretion of IF

31 increase fat uptake with HFD, whereas tumor-infiltrating CD8(+) T cells do not.

32 s, a comparison of these cells with melanoma-infiltrating CD8(+) T cells revealed upregulated cytokin

33 Chop expression is increased in tumor-infiltrating CD8(+) T cells, which correlates with poor

34 expression concomitant with higher number of infiltrating CD8(+) T cells.

35 There was no increase in tumor infiltrating CD8+ T cells expressing "exhaustion" marker

36 Tumor-infiltrating CD8+ T cells mediate antitumor immune respo

37 Tumor-infiltrating CD8-positive (CD8+) T lymphocytes play a ce

38 Infiltrating CD8alpha(+) cells were TCRalphabeta T cells

39 roposed to explain how these multiple tumour-infiltrating cell types block the development of an effe

40 rine signals with other cancer cells and the infiltrating cell types that populate the microenvironme

41 an uveitis and healthy tissues suggests that infiltrating cells could be targeted by inhibitors of th

42 med an unbiased examination of diverse islet-infiltrating cells during autoimmune diabetes in the non

43 llowing activation in vitro, whereas retinal infiltrating cells expressed LTB(4)R and C5aR.

44 e-cell analysis of intrinsic renal cells and infiltrating cells from patients with LN is a new approa

45 Analysis of tumor-infiltrating cells in dual PARP-1/PARP-2-deficiency host

46 ir associated receptor expression by retinal infiltrating cells in mouse and human tissues, and in at

47 T cell proliferation and polarization, renal infiltrating cells, and cytokines in wild-type and NGAL-

48 mitigation of the inflammatory status of the infiltrating cells, improved electrophysiologic visual f

49 myeloid, mesenchymal) and abundance of tumor-infiltrating cells.

50 ation, where inflammation was defined as >14 infiltrating cells/mm(2).

51 topodin, in parietal epithelial cells (PECs) infiltrating cFSGS glomeruli.

52 the first time complete regression of a non-infiltrating ciliary body medulloepithelioma with seedin

53 ical type, Scarf-Bloom, Ki67, and p53 in the infiltrating component as well as in the in situ compone

54 pancreas and lung cancer are differences in infiltrating conventional dendritic cells (cDCs).

55 t with a reduction in TAMs the percentage of infiltrating cytotoxic T cells is increased, indicating

56 organisms revealed that the numbers of tumor-infiltrating dendritic cells (TIDC) drastically decrease

57 ncluding tumor-associated macrophages, tumor-infiltrating dendritic cells and regulatory T cells.

58 ansfecting a substantial proportion of tumor-infiltrating dendritic cells, macrophages, and T cells i

59 luded 4 intraductal carcinoma (33.33%) and 7 infiltrating ductal carcinoma (58.33%).

60 3), the most common histologic subtypes were infiltrating ductal carcinoma (IDC, 84.9%) and luminal A

61 ALK5(DeltaCD8) mice have more tumor-infiltrating effector CD8(+) T cells, with more cytotoxi

62 t with a reduction in central nervous system-infiltrating effector T cells (Teff cells).

63 bearing mregDC1s, expands the pool of tumour-infiltrating effector T cells and reduces tumour burden.

64 , a DNA hypomethylating drug increases tumor-infiltrating effector T cells, increases a subset of M2

65 Knowledge of infiltrating endometriosis and its ultrasonographic feat

66 This paper illustrates the findings for infiltrating endometriosis involving the bowel and urina

67 essed in TMEs and induces apoptosis in tumor-infiltrating, Fas receptor-positive lymphocytes.

68 We identify graft-infiltrating gamma-delta (gammadelta) T cells and Type 3

69 containing protein 3 (TIM-3) expressed by TG infiltrating gB-specific CD8(+) T cells from the HSV-1 0

70 sy-proven patient data identified as diffuse infiltrating glioma patients whose disease progressed/re

71 ignificant challenge in follow-up of diffuse infiltrating gliomas, particularly high grade, which lea

72 by phagocytic resident liver macrophages and infiltrating Gr-1(+) myeloid cells.

73 Interestingly, we found these infiltrating granulocytes to be SSC(high) CD11b(+) CD125

74 iagnosis was based on findings of eosinophil-infiltrating granulomatous vasculitis of the skin accomp

75 cell infiltration and the migratory path of infiltrating H3K27M DMG cells into other midline structu

76 Infiltrating host mononuclear cells are a likely source

77 Finally, a higher proportion of bone marrow-infiltrating ICOShigh/PD-1- Treg cells is a highly signi

78 romoting the expansion of peripheral and CNS-infiltrating IL-10(+) T cells.

79 In SD lesions, dermal infiltrating IL-31(+) cells were increased in number com

80 We found the immune cells infiltrating IL-36alpha-injected mouse skin to be of dra

81 g ("rebooting") pre-existing exhausted tumor-infiltrating ilymphocytes (TILs).

82 ramatically different composition than those infiltrating imiquimod-treated skin.

83 imilar subtypes, characterized by changes to infiltrating immune and stromal expression signatures.

84 IFNs are produced not only by infiltrating immune but also resident skin cells, with i

85 nalysis of genomic, transcriptomic and tumor-infiltrating immune cell profiles demonstrated alignment

86 gs promoted the assembly of ASC complexes in infiltrating immune cells (neutrophils and inflammatory

87 inflammatory mediators and increasing tumour-infiltrating immune cells - phenomena often described co

88 Immunohistochemical staining for infiltrating immune cells and expression analyses of inf

89 Tumor-infiltrating immune cells comprise a previously unrecogn

90 e (ie, patients with PD-L1-expressing tumour infiltrating immune cells covering >=1% of tumour area)

91 e tumor microenvironment (TME) that prevents infiltrating immune cells from performing their anticanc

92 We characterize tumor-infiltrating immune cells from transplant and primary tu

93 Despite infiltrating immune cells having an essential function i

94 Macrophages are the main infiltrating immune cells in choroidal neovascularizatio

95 examined steroid hormone receptors and tumor-infiltrating immune cells in metastatic lesions with or

96 bution of Notch3 expression in tissue versus infiltrating immune cells is unknown.

97 The ability of tumor-infiltrating immune cells to promote tumor growth via th

98 Notably, tumour-infiltrating immune cells typically experience metabolic

99 Infiltrating immune cells were predominately neutrophils

100 s the proportions of stromal cells and tumor-infiltrating immune cells, as well as associations of th

101 an interferon signature in the skin without infiltrating immune cells, but with interferon-kappa pro

102 Tumor-infiltrating immune cells, especially CD3(+) T cells, sh

103 onally, by modulating the reuptake of tissue-infiltrating immune cells, lymphatics regulate immune re

104 s evaluated by immunohistochemistry in tumor infiltrating immune cells, while PD-L1 expression in the

105 rosstalk between stressed resident cells and infiltrating immune cells.

106 nalysis and visualization functions of tumor infiltrating immune cells.

107 al mechanisms, including the contribution of infiltrating immune cells.

108 r metastases, and PD-L1 expression on tumour-infiltrating immune cells.

109 ers in a scRNAseq experiment involving tumor-infiltrating immune cells.

110 1alpha protein stabilization was observed in infiltrating immune cells.

111 Twist1 in infiltrating inflammatory macrophages but not in residen

112 (2019) demonstrate a novel role for tumor-infiltrating innate-like B1a B cells in promoting melano

113 as a reduction in the number of immune cells infiltrating into the brain, mitigation of the inflammat

114 es in women in whom radical excision of deep infiltrating lesions is obtained.

115 Infiltrating leukocytes and tissue adaptations increase

116 Brain-infiltrating leukocytes are also primary targets for MS

117 Brain-infiltrating leukocytes contribute to multiple sclerosis

118 e antigen-4 (CTLA-4), respectively, on tumor-infiltrating leukocytes eliciting immunosuppression.

119 onclusion: (18)F-FAC PET can visualize brain-infiltrating leukocytes in a mouse MS model and can moni

120 suggest that (18)F-FAC accumulates in brain-infiltrating leukocytes in this model.

121 eoxyribonucleoside salvage activity in brain-infiltrating leukocytes was analyzed ex vivo.

122 rmine whether (18)F-FAC accumulates in brain-infiltrating leukocytes, EAE mice were analyzed with (18

123 itated the targeted gene expression in tumor-infiltrating leukocytes, including antigen-presenting de

124 18)F-FAC PET could noninvasively image brain-infiltrating leukocytes.

125 actions with cancer cells and crosstalk with infiltrating leukocytes.

126 effect of an immunomodulatory drug on brain-infiltrating leukocytes.

127 r upregulation of pathways and enrichment of infiltrating leukocytes.

128 is (EAE) is a mouse disease model with brain-infiltrating leukocytes.

129 s in malignant and stromal cells, as well as infiltrating leukocytes.

130 tumor cells showed >80% GFP marking in tumor-infiltrating leukocytes.

131 odel, the frequency of PD-1-expressing tumor-infiltrating LSD1-deficient CD8 T cells was greater than

132 ds in the prediction of infiltrating and non-infiltrating lymph nodes, and the determination of their

133 Finally, we evaluated the immune cell tumor-infiltrating lymphocyte (TIL) score for correlation with

134 oint blockade and adoptive transfer of tumor-infiltrating lymphocyte (TIL)-based therapies.

135 hocytes in a subset of TNBCs with high tumor-infiltrating lymphocyte content.

136 esolution subgroup significantly depended on infiltrating lymphocyte counts, with patients who showed

137 Tumor-infiltrating lymphocyte estimated using immune cell sign

138 tions between functional hypoxia imaging and infiltrating lymphocyte levels as a potential predictor

139 We also mined a tumor-infiltrating lymphocyte sample from a patient with melan

140 vestigation, we explored the effect of tumor-infiltrating lymphocyte subpopulations on lung cancer bi

141 on, cytolytic activity, and abundance (tumor infiltrating lymphocyte, TIL, burden).

142 nodal status (N0 vs rest), number of tumour-infiltrating lymphocytes (continuous variable), subtype

143 Direct competition between tumor-infiltrating lymphocytes (TIL) and cancer cells for meta

144 Here, we show that P2X7 activity in tumor-infiltrating lymphocytes (TIL) induces cellular senescen

145 of spatial relations between tumor and tumor-infiltrating lymphocytes (TIL) is increasingly important

146 DAC led to increased CD4(+) and CD8(+) tumor-infiltrating lymphocytes (TIL), PD1 expression, and tumo

147 mal toxicity in ex vivo-expanded human tumor-infiltrating lymphocytes (TIL), proliferating TILs, and

148 en-specific, activated effector CD8(+) tumor-infiltrating lymphocytes (TILs) after interaction with t

149 d the role of CD226 in the function of tumor-infiltrating lymphocytes (TILs) and resistance to immuno

150 latory microenvironment harboring more tumor infiltrating lymphocytes (TILs) and up-regulation of inf

151 Tumor-infiltrating lymphocytes (TILs) are an important histopa

152 ACT) using ex vivo-expanded autologous tumor-infiltrating lymphocytes (TILs) can mediate complete reg

153 rvivors had a reduced frequency of CD8 tumor-infiltrating lymphocytes (TILs) concomitant with an incr

154 enhances the expansion and function of tumor-infiltrating lymphocytes (TILs) for treating cancer pati

155 cterisation and clinical relevance of tumour-infiltrating lymphocytes (TILs) in leiomyosarcoma (LMS),

156 ultifunctionality of CD8 + splenic and tumor-infiltrating lymphocytes (TILs) was impaired and associa

157 The distribution of tumor-infiltrating lymphocytes (TILs) within the tumor microen

158 ing from naive to dysfunctional CD8(+) tumor-infiltrating lymphocytes (TILs).

159 hare core residency gene programs with tumor-infiltrating lymphocytes (TILs).

160 cell therapy (ACT) of ex vivo expanded tumor-infiltrating lymphocytes (TILs).

161 Intraepithelial/stromal tumor-infiltrating lymphocytes (TILs; CD3(+)/CD4(+)/CD8(+)/CD4

162 d a higher response of patient-matched tumor infiltrating lymphocytes against antigens diferentially

163 d, inhibits RANK pathway and increases tumor infiltrating lymphocytes and CD8(+) T cells.

164 Tumour-infiltrating lymphocytes are associated with a survival

165 at MHC class II (MHCII) expression and tumor infiltrating lymphocytes are important prognostic factor

166 hat the presence and quantification of tumor-infiltrating lymphocytes are significantly associated wi

167 Rationale Tumor infiltrating lymphocytes are widely associated with posi

168 Generation of tumor-infiltrating lymphocytes begins when tumor antigens reac

169 ccessible in Nr4a triple knockout CAR tumour-infiltrating lymphocytes compared to wild type were enri

170 CD8(+) tumor-infiltrating lymphocytes displayed low expression of CD2

171 Nr4a triple knockout CAR tumour-infiltrating lymphocytes displayed phenotypes and gene e

172 n the presence of Wnt5A-depleted MDSC, tumor-infiltrating lymphocytes expressed decreased PD-1 and LA

173 FK_pY416 staining was also observed in tumor-infiltrating lymphocytes in a subset of TNBCs with high

174 y of this tool by using it to classify tumor-infiltrating lymphocytes in breast carcinoma and cutaneo

175 in part because of the low number of tumour-infiltrating lymphocytes in most breast cancers.

176 ssion is increased in keratinocytes and skin-infiltrating lymphocytes of psoriatic lesions in human s

177 lies on reinvigoration of pre-existing tumor-infiltrating lymphocytes or on recruitment of novel T ce

178 Examination of tumor-infiltrating lymphocytes revealed an elevated population

179 SWe recently developed a process using tumor-infiltrating lymphocytes to identify the specific immuno

180 omeostatic myeloid cells were outnumbered by infiltrating lymphocytes which modulated the local cell-

181 d enhancement of antitumor activity in tumor-infiltrating lymphocytes without disrupting immune homeo

182 of lymphokine-activated killer cells, tumour-infiltrating lymphocytes, and allogeneic haemopoietic st

183 at rapidly proliferating cancer cells, tumor-infiltrating lymphocytes, and vascular endothelial cells

184 rognostic significance of intratumoral tumor infiltrating lymphocytes, as well as subsets of CD3, CD8

185 gene, Ki-67 proliferation marker, and tumor-infiltrating lymphocytes, carry prognostic significance,

186 clinical-pathological data on stromal tumour-infiltrating lymphocytes, PAM50 subtypes, and expression

187 18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy

188 -L1 expression in both tumor cells and tumor-infiltrating lymphocytes, suggesting that immune checkpo

189 and immunohistochemical stainings for tumor-infiltrating lymphocytes, tissue-based hypoxia, and micr

190 iers to the metabolism and activity of tumor infiltrating lymphocytes.

191 wth was measured by serial ultrasound, tumor-infiltrating lymphoid and myeloid cells were characteriz

192 nd increases both TILs and a subset of tumor-infiltrating M2-polarized macrophages in the KPC model o

193 reflecting an increase in a subset of tumor-infiltrating M2-polarized macrophages.

194 r metabolite and protein differences between infiltrating macrophage phenotypes.

195 urther, during chronic neuroinflammation CNS-infiltrating macrophages and not peripheral myeloid cell

196 Moreover, deletion of Twist1 in infiltrating macrophages attenuated the expression of MM

197 persistent DNA damage accumulation in tissue-infiltrating macrophages carrying an ERCC1-XPF DNA repai

198 In the present study we isolated liver infiltrating macrophages from mice on an ethanol diet an

199 signature and CD274 gene expression in tumor-infiltrating macrophages in humans.

200 Infiltrating macrophages promote inflammation and simult

201 Furthermore, comparison of diseased KCs and infiltrating macrophages revealed that these two macroph

202 These infiltrating macrophages secrete SPP1, which sustains gl

203 rated neutrophils, and then overexpressed in infiltrating macrophages, AnxA1 activated FPR2/ALX recep

204 neutrophils and Ly6C(hi) and Ly6C(lo) muscle-infiltrating macrophages, with a distinct pro-resolving

205 TREM2 is also expressed by tumor-infiltrating macrophages.

206 genes shared between a microglia cluster and infiltrating macrophages.

207 innate immune response and increasing tumor infiltrating macrophages.

208 mmunogenic cell death and the recruitment of infiltrating macrophages.

209 tissue is mostly composed of neurons and few infiltrating malignant cells.

210 euro-oncology MRI data can already delineate infiltrating margins of diffuse gliomas, differentiate p

211 Tumor-infiltrating MDSC from control animals showed a strong p

212 are a large number of circulating and tumor-infiltrating MDSCs existing in gastric cancer (GC) patie

213 ddition, our investigation showed that tumor-infiltrating MDSCs from 6 GAC patients consisted of >35%

214 We found that a subset of liver-infiltrating monocyte-derived CD11c(+) cells co-expressi

215 nt models demonstrated an association of CNS-infiltrating monocyte-derived macrophages with disease s

216 onal abundance of tissue-resident microglia, infiltrating monocyte-derived macrophages, neutrophils,

217 hages, describe possible mechanisms by which infiltrating monocytes acquire unique macrophage fates,

218 file of blood-derived monocytes versus tumor-infiltrating monocytes and found increased expression of

219 sophil-derived interleukin-4 can act on lung-infiltrating monocytes causing aberrant expression of th

220 tanding the respective role of microglia and infiltrating monocytes in neuroinflammatory conditions h

221 Decreased numbers of infiltrating monocytes were observed in healing wounds f

222 pro- and anti-inflammatory pathways in tumor infiltrating monocytes.

223 nalysis shows the expression of GPR35 on the infiltrating monocytes/macrophages and neutrophils in th

224 the frequency of myeloid-derived cells, both infiltrating monocytes/macrophages and resident microgli

225 s, including neurons, astrocytes, microglia, infiltrating monocytes/macrophages, lymphocytes, and oth

226 Here, we report that STAT3 is activated in infiltrating monocytic cells near active MS lesions and

227 phenotypic profile resembling that of tumor infiltrating myeloid and lymphoid populations, but with

228 This study ultimately demonstrates that infiltrating myeloid cell TGF-beta1 is responsible for t

229 Tumour-infiltrating myeloid cells (TIMCs) are critical regulato

230 troke, we characterized the phenotypes of CP-infiltrating myeloid cells after transient middle cerebr

231 th resulted in significantly decreased brain-infiltrating myeloid cells as well as attenuated cachexi

232 polarization of central nervous system (CNS)-infiltrating myeloid cells into an antiinflammatory/repa

233 s cytometry revealed a wide heterogeneity of infiltrating myeloid cells with increased infiltration o

234 Understanding the migratory patterns of CP-infiltrating myeloid cells with intact and disrupted CX3

235 cy on the development of AAA by reduction of infiltrating myeloid cells.

236 s well as the number and functions of tumour-infiltrating natural-killer and CD8(+) T lymphocytes.

237 Importantly, infiltrating nerves not only influence the tumor cells t

238 is currently known about the origin of tumor-infiltrating nerves, how they may be recruited to tumors

239 facilitate their maturation into adrenergic infiltrating nerves.

240 We demonstrated in a recent study that tumor-infiltrating neutrophil density correlated with TC size.

241 rface CD62L and upregulation of Cxcr4, heart infiltrating neutrophils acquired a unique SiglecF(hi) s

242 Host defense against IA relies on lung-infiltrating neutrophils and monocyte-derived dendritic

243 g the expression of these receptors on tumor-infiltrating NK cells in human tumors, whereas tumor cel

244 targeting versus CD56 for detection of tumor infiltrating NK cells.

245 , and NKp46 to determine expression on tumor-infiltrating NK cells.

246 Finally, we find that tumor infiltrating NKT cells are highly enriched for the YY1(l

247 significantly reduced numbers of bone marrow-infiltrating OX40+ cytotoxic T cells and helper T cells,

248 associated with decreased frequency of tumor-infiltrating PD-L1(+)CD11b(+)Gr1(+) MDSC.

249 of studies did not evaluate the presence of infiltrating peripheral immune cells in the central nerv

250 , including their interaction with allograft-infiltrating recipient immune cells and potential therap

251 riminate the liver-resident (donor) from the infiltrating (recipient) immune composition.

252 covered a significant heterogeneity of tumor-infiltrating slan(+) -cells, including a macrophage-like

253 Tumor-infiltrating stromal cells, which include macrophages/mi

254 owever, in advanced stages, cancer cells and infiltrating stromal components interfere with the immun

255 In turn, infiltrating sympathetic nerves facilitate cancer progre

256 tivity is present at similar levels in brain-infiltrating T and innate immune cells.

257 mation, which is reflected by high levels of infiltrating T cells and interferon-gamma (IFNgamma) sig

258 There were more tumor-infiltrating T cells and MHCII(hi)-immune cells in tumor

259 omise in a variety of cancers, but how tumor-infiltrating T cells are activated remains unclear.

260 umors grow slower than in wild-type mice and infiltrating T cells are less exhausted and more active

261 s the expression of CTLA-4 molecule on tumor-infiltrating T cells by siRNA-loaded chitosan-lactate (C

262 The majority of tumor-infiltrating T cells exhibit a terminally exhausted phen

263 Gene expression analyses of tumor-infiltrating T cells following Yap deletion implicates Y

264 ished tumors promotes re-activation of tumor-infiltrating T cells for tumor control.

265 Tumor-infiltrating T cells mainly displayed exhausted and regu

266 ponses to HIPs were observed among the islet-infiltrating T cells of pancreatic organ donors and in t

267 Presence of tumor-infiltrating T cells, but not programmed death-ligand 1

268 onment, including increased numbers of tumor-infiltrating T cells, elevated IFN signaling, and immune

269 roenvironment, significantly increased tumor infiltrating T cells, lowered the hypoxia level, decreas

270 ed to the downregulation of CTLA-4 on tumor -infiltrating T cells, which was associated with tumor re

271 with an ipilimumab-induced increase in tumor-infiltrating T cells.

272 nd altered polarization and pathogenicity of infiltrating T cells.

273 o immune checkpoint therapy due to few tumor-infiltrating T cells.

274 sms of resistance of liver tumors in mice to infiltrating T cells.

275 eases MLK3 and Ppia gene expression in tumor-infiltrating T cells.

276 growth by suppressing the activity of tumor-infiltrating T cells.

277 ilar means as those used to reactivate tumor-infiltrating T lymphocytes (TIL), for example, by cytoki

278 hared antigenic epitopes recognized by tumor-infiltrating T lymphocytes (TILs) from eight melanoma pa

279 olic fitness and antitumor activity of tumor-infiltrating T lymphocytes (TILs).

280 Immunogenic cell death (ICD) and tumour-infiltrating T lymphocytes are severely weakened by elev

281 mune checkpoint molecules expressed on tumor-infiltrating T lymphocytes, such as cytotoxic T-lymphocy

282 h NGAL-deficient neutrophils with more renal infiltrating T(H)17 cells.

283 ted the involvement of virus-specific, joint-infiltrating Th1 cells as one of the main pathogenic med

284 CXCL2 expression, prevents macrophages from infiltrating the bite site, protects susceptible IFNAR(-

285 Collective glioma networks infiltrating the brain thus depend on adherens junctions

286 we show that memory phenotype CD4(+) T cells infiltrating the central nervous system during experimen

287 e cells appear to respond to noise damage by infiltrating the organ of Corti.

288 Moreover, immune cells infiltrating the pancreas of humans with T1D exhibited i

289 subset bias was observed among GC Tfh cells infiltrating the pancreas of NOD mice, which was enhance

290 e 3D distribution and density of lymphocytes infiltrating the tissue, and by providing histograms of

291 main trajectory of human slan(+) -monocytes infiltrating the tonsil tissue is toward a macrophage-li

292 nal form of EB have significantly more cells infiltrating their wounds compared with patients with re

293 Results: High levels of tumor-infiltrating total lymphocytes correlated with superior

294 icroenvironment and the composition of tumor-infiltrating Treg and myeloid-derived suppressor cells.

295 molecules preferentially expressed on tumor-infiltrating Tregs.

296 Tumor-infiltrating Trx1+ NK cells were present in patients wit

297 Macrophages are a major immune cell type infiltrating tumors and promoting tumor growth and metas

298 The pathology revealed diffusely and deeply infiltrating tumour cells extending through the dermis,

299 sion is altered at the surface of leukocytes infiltrating unhealed atherothrombotic lesions and that

300 However, the roles of infiltrating versus resident myeloid cells in these oppo